10 completed, 1 terminated. 11 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 10, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow istradefylline: new trials by email Literature Review of istradefylline trials Research Report on istradefylline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease Istradefylline 20 mg or 40 mg - Idiopathic Parkinson's Disease | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 239 | 2015-12-01 | 2024-04-25 |
| A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease Istradefylline 40 mg, Istradefylline 20 mg, Placebo - Idiopathic Parkinson's Disease | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 613 | 2013-10-01 | 2024-04-25 |
| Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients Istradefylline - Parkinson's Disease | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 308 | 2009-10-01 | 2012-08-31 |
| Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa Istradefylline, Placebo - Parkinson's Disease | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 373 | 2009-07-01 | 2012-08-29 |
| An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001 Istradefylline - Parkinson's Disease | Phase 3 | Terminated | Kyowa Kirin, Inc. | 504 | 2005-10-01 | 2024-05-17 |
| Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa Istradefylline - Parkinson's Disease | Phase 3 | Completed | University of Chicago | 10 | 2005-03-01 | 2013-06-11 |
| A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease Istradefylline (KW-6002) - Parkinson's Disease | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 405 | 2004-11-01 | 2024-04-25 |
| An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018 Istradefylline ( KW-6002) - Parkinson's Disease | Phase 3 | Completed | Kyowa Kirin, Inc. | 1100 | 2004-10-01 | 2024-04-25 |
| A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa Istradefylline (KW-6002) - Parkinson's Disease | Phase 3 | Completed | Kyowa Kirin, Inc. | 580 | 2004-07-01 | 2024-04-25 |
| A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa Istradefylline (KW-6002) - Parkinson's Disease | Phase 3 | Completed | Kyowa Kirin, Inc. | 230 | 2004-06-01 | 2024-04-25 |
| A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy istradefylline - Parkinson's Disease | Phase 2 / Phase 3 | Completed | Kyowa Kirin, Inc. | 2002-08-01 | 2024-04-25 |
Parkinson Disease (11)
Kyowa Kirin Co., Ltd. (5) · Kyowa Kirin, Inc. (5) · University of Chicago (1)
United States (8) · Canada (2) · Czechia (2) · Germany (2) · Israel (2) · Italy (2) · Japan (2) · Poland (2) · Serbia (2) · United Kingdom (1)
Neil Sussman, MD (4) · Arif Dalvi, M.D. (1)